Fenofibrate slows diabetic retinopathy progression

Trial data has shown that the old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with the potential of reducing the need for retinal laser or intravitreal injection treatment. In the LENS trial of more than 1100 people randomly assigned to fenofibrate or […]

Texture-based analysis of OCT images reveals early retinal changes in diabetes

news.medical.net - 14:22

Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults, affecting more than 130 million people worldwide.

Texture-based analysis of OCT images reveals early retinal changes in diabetes

news.medical.net - 14:22

Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults, affecting more than 130 million people worldwide.

New drug could reduce ‘bad’ cholesterol by 60%, prevent heart attacks without injections

knowridge.com - 14/Nov 10:54

A new pill developed by the drug company Merck may soon help millions of people lower their cholesterol and reduce the risk of heart attacks and...

Renewable diesel trial by Rio Tinto shows path to decarbonisation

australianmining.com.au - 26/Nov 04:31

The Rio Tinto–Viva Energy trial demonstrates that scalable solutions for reducing emissions exist. Image: Viva EnergyA landmark trial has shown...

HC raps trial court for ‘lethargic’ handling of 20-year-old case

hindustantimes.com - 25/Nov 15:14

“The Judiciary, like all other organs of the state, is equally accountable to the people. The presiding officer of the trial court, therefore, has...

Eylea HD (aflibercept) Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

drugs.com - 19/Nov 22:11

TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug...

Rubriques :

Fenofibrate slows diabetic retinopathy progression

Articles similaires

Texture-based analysis of OCT images reveals early retinal changes in diabetes

Texture-based analysis of OCT images reveals early retinal changes in diabetes

New drug could reduce ‘bad’ cholesterol by 60%, prevent heart attacks without injections

Renewable diesel trial by Rio Tinto shows path to decarbonisation

HC raps trial court for ‘lethargic’ handling of 20-year-old case

Eylea HD (aflibercept) Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

Computer Chips Could Be the Future of Medicine

Computer Chips Could Be the Future of Medicine

UBC researchers reveal how statins trigger muscle damage

Diabetic Macular Edema Pipeline Drugs Landscape Report 2025: MOA Analysis, R&D Progress, Clinical Trial Pipeline, ...

Les derniers communiqués